GENEVA, April 4 -- GUANGZHOU BIOSYNGEN CO., LTD. (Room 318-321, Building2, No.1 Tengfei Street, Sino-Singapore Knowledge City, Huangpu DistrictGuangzhou, Guangdong 510555), 广州百吉生物制药有限公司 (中国广东省广州市黄埔区中新广州知识城腾飞一街2号318-321房) filed a patent application (PCT/CN2024/125825) for "CULTURE MEDIUM FOR TUMOR INFILTRATING LYMPHOCYTES AND IN VITRO EXPANSION CULTURE METHOD" on Oct 18, 2024. With publication no. WO/2026/065612, the details related to the patent application was published on Apr 02, 2026.
Nota...